355 related articles for article (PubMed ID: 34349894)
1. Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.
Shariq OA; McKenzie TJ
Ther Adv Chronic Dis; 2021; 12():20406223211033103. PubMed ID: 34349894
[TBL] [Abstract][Full Text] [Related]
2. Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.
Ettaieb M; Kerkhofs T; van Engeland M; Haak H
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414074
[TBL] [Abstract][Full Text] [Related]
3. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
4. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
5. Mitotane treatment for adrenocortical carcinoma: an overview.
De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
[TBL] [Abstract][Full Text] [Related]
6. Developing treatment for adrenocortical carcinoma.
Kerkhofs TM; Ettaieb MH; Hermsen IG; Haak HR
Endocr Relat Cancer; 2015 Dec; 22(6):R325-38. PubMed ID: 26259571
[TBL] [Abstract][Full Text] [Related]
7. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment.
Libé R
Front Cell Dev Biol; 2015; 3():45. PubMed ID: 26191527
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of adrenocortical carcinoma.
Zini L; Porpiglia F; Fassnacht M
Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
[TBL] [Abstract][Full Text] [Related]
10. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions.
Bedrose S; Daher M; Altameemi L; Habra MA
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098326
[TBL] [Abstract][Full Text] [Related]
12. Approach to the patient with adrenocortical carcinoma.
Lacroix A
J Clin Endocrinol Metab; 2010 Nov; 95(11):4812-22. PubMed ID: 21051577
[TBL] [Abstract][Full Text] [Related]
13. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
15. Medical Approaches in Adrenocortical Carcinoma.
Paragliola RM; Corsello A; Locantore P; Papi G; Pontecorvi A; Corsello SM
Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33260476
[TBL] [Abstract][Full Text] [Related]
16. New perspectives for mitotane treatment of adrenocortical carcinoma.
Puglisi S; Calabrese A; Basile V; Pia A; Reimondo G; Perotti P; Terzolo M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101415. PubMed ID: 32179008
[TBL] [Abstract][Full Text] [Related]
17. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
[TBL] [Abstract][Full Text] [Related]
18. Update on adrenocortical carcinoma management and future directions.
Varghese J; Habra MA
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):208-214. PubMed ID: 28277340
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: Adrenocortical carcinoma: clinical update.
Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2027-37. PubMed ID: 16551738
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options.
Al-Ward R; Zsembery C; Habra MA
Endocr Oncol; 2022 Jan; 2(1):R90-R101. PubMed ID: 37435451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
